Oncotelic Therapeutics Buy Hold or Sell Recommendation
| OTLCDelisted Stock | USD 0.02 0 6.38% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Oncotelic Therapeutics is 'Not Rated'. Macroaxis provides Oncotelic Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding OTLC positions.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. In addition, we conduct extensive research on individual companies such as Oncotelic and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Oncotelic Therapeutics. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Oncotelic |
Execute Oncotelic Therapeutics Buy or Sell Advice
The Oncotelic recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Oncotelic Therapeutics. Macroaxis does not own or have any residual interests in Oncotelic Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Oncotelic Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Oncotelic Therapeutics Trading Alerts and Improvement Suggestions
| Oncotelic Therapeutics is not yet fully synchronised with the market data | |
| Oncotelic Therapeutics has some characteristics of a very speculative penny stock | |
| Oncotelic Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Oncotelic Therapeutics currently holds 9.8 M in liabilities with Debt to Equity (D/E) ratio of 0.4, which is about average as compared to similar companies. Oncotelic Therapeutics has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Oncotelic Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Oncotelic Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Oncotelic Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Oncotelic to invest in growth at high rates of return. When we think about Oncotelic Therapeutics' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (9.39 M) with profit before overhead, payroll, taxes, and interest of 1.74 M. | |
| Oncotelic Therapeutics currently holds about 399.77 K in cash with (4.43 M) of positive cash flow from operations. | |
| Roughly 56.0% of Oncotelic Therapeutics outstanding shares are owned by corporate insiders |
Oncotelic Therapeutics Returns Distribution Density
The distribution of Oncotelic Therapeutics' historical returns is an attempt to chart the uncertainty of Oncotelic Therapeutics' future price movements. The chart of the probability distribution of Oncotelic Therapeutics daily returns describes the distribution of returns around its average expected value. We use Oncotelic Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Oncotelic Therapeutics returns is essential to provide solid investment advice for Oncotelic Therapeutics.
| Mean Return | -0.25 | Value At Risk | -25 | Potential Upside | 25.00 | Standard Deviation | 14.27 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Oncotelic Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Oncotelic Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Oncotelic . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Oncotelic Therapeutics Buy or Sell Advice
When is the right time to buy or sell Oncotelic Therapeutics? Buying financial instruments such as Oncotelic OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Oncotelic Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Construction Materials Thematic Idea Now
Construction Materials
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Construction Materials theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Construction Materials Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Oncotelic OTC Stock
If you are still planning to invest in Oncotelic Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oncotelic Therapeutics' history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |